Literature DB >> 1085215

Use of the complement fixation (CF) test in Lassa fever surveillance. Evidence for persistent CF antibodies.

A Fabiyi, O Tomori.   

Abstract

A survey to detect individuals with antibodies to Lassa virus was undertaken among hospital personnel in the eastern and southern provinces of Sierra Leone late in 1974. Sera were evaluated by the complement fixation test. The data obtained showed that some contacts of Lassa fever patients in the 1972 epidemic had developed antibodies to the virus; individuals who had never reported being sick also showed evidence of infection, with significant CF antibody titres in their sera. Surviving Lassa fever patients from the 1972 epidemic still had easily measurable levels of persisting CF antibodies. The significance of these data is discussed; in addition it is recommended that the CF test should continue to be the method of choice in mass surveys for this virus disease until other tests can be developed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1085215      PMCID: PMC2366643     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases.

Authors:  T P Monath; M Maher; J Casals; R E Kissling; A Cacciapuoti
Journal:  Am J Trop Med Hyg       Date:  1974-11       Impact factor: 2.345

2.  A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972.

Authors:  T P Monath; P E Mertens; R Patton; C R Moser; J J Baum; L Pinneo; G W Gary; R E Kissling
Journal:  Am J Trop Med Hyg       Date:  1973-11       Impact factor: 2.345

3.  Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.

Authors:  S M Buckley; J Casals
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

4.  Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone.

Authors:  T P Monath; V F Newhouse; G E Kemp; H W Setzer; A Cacciapuoti
Journal:  Science       Date:  1974-07-19       Impact factor: 47.728

  4 in total
  3 in total

1.  Lassa, Marburg and Ebola: newly described African fevers.

Authors:  S K Seah
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

Review 2.  Infectious diseases in Africa.

Authors:  E A Ayoola
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

3.  A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.

Authors:  Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby
Journal:  BMC Med       Date:  2019-06-11       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.